Author : Barry Werth
Publisher : Simon and Schuster
Page : 480 pages
File Size : 40,23 MB
Release : 1995-03
Category : Business & Economics
ISBN : 0671510576
This inside account of Vertex, a start-up pharmaceutical company, conveys the exciting drama being played out in the pioneering and enormously profitable field of drug research. Vertex is dedicated to designing--atom by atom--a new life-saving immunosuppressant drug that has major implications for HIV research.
Author : Barry Werth
Publisher : Simon and Schuster
Page : 448 pages
File Size : 18,14 MB
Release : 2014-02-04
Category : Business & Economics
ISBN : 1451655665
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Journalist Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell the story of Vertex's bold endurance and eventual success. The pharmaceutical business is America's toughest and one of its most profitable. It's riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's 25-year drive to deliver breakthrough medicines.--From publisher description.
Author : Charles Theuer
Publisher : Forbesbooks
Page : 192 pages
File Size : 15,79 MB
Release : 2021-09-21
Category : Business & Economics
ISBN : 9781950863570
The drug development process in the United States has become so weighted down by a business-as-usual paradigm that an average of more than $2 billion is spent to secure FDA approval for every new drug. Because the investment required is so extreme, drug development companies are understandably focused on discovering and developing drugs designed for large patient populations: diseases experienced by millions, such as high blood pressure, diabetes, or some of the more common cancers. In Unnecessary Expense, Dr. Charles Theuer, CEO of TRACON Pharmaceuticals, outlines the problem and offers a solution: an aligned and streamlined model that emphasizes quality and reduces the time and cost of drug development, while also harnessing global innovation to benefit patients with rare diseases in urgent need of new treatments. Here Dr. Theuer shows the value of a pharmaceutical paradigm shift, to enable the development of drugs for patients who need them, at a fraction of the time and cost.
Author : Judit Pongracz
Publisher : Elsevier Health Sciences
Page : 207 pages
File Size : 38,87 MB
Release : 2009-01-01
Category : Medical
ISBN : 0080451357
"Biotechnology encompasses the variety of methods available for manipulating living cells and organisms. It is having an increasing impact on all aspects of medicine, from helping in the understanding of the aetiology of disease, to its diagnosis and treatment. This growing importance of medical biotechnology means that a general understanding of this rapidly advancing field is essential for all medical graduates and medical scientists. This book places emphasis on the medical applications of biotechnology, rather than the details fo the experimental techniques"--Back cover.
Author : K. C. Nicolaou
Publisher : Wiley-VCH
Page : 0 pages
File Size : 14,91 MB
Release : 2008-03-17
Category : Science
ISBN : 9783527309832
K.C. Nicolaou - Winner of the Nemitsas Prize 2014 in Chemistry Here, the best-selling author and renowned researcher, K. C. Nicolaou, presents around 40 natural products that all have an enormous impact on our everyday life. Printed in full color throughout with a host of pictures, this book is written in the author's very enjoyable and distinct style, such that each chapter is full of interesting and entertaining information on the facts, stories and people behind the scenes. Molecules covered span the healthy and useful, as well as the much-needed and extremely toxic, including Aspirin, urea, camphor, morphine, strychnine, penicillin, vitamin B12, Taxol, Brevetoxin and quinine. A veritable pleasure to read.
Author : Barry Werth
Publisher : Anchor
Page : 418 pages
File Size : 41,43 MB
Release : 2007-02-13
Category : Political Science
ISBN : 1400078687
In 31 Days, acclaimed historian Barry Werth takes readers inside the White House during the tumultuous days of August 1974, following Richard Nixon's resignation and the swearing-in of America's "accidental president," Gerald Ford. The Watergate scandal had torn the country apart. In a dramatic, day-by-day account of the new administration’s inner workings, Werth shows how Ford, caught between political expedience, the country’s demands for justice, and his own moral compass, struggled valiantly to restore the nation’s tarnished faith in its leadership. With deft and refreshing analysis Werth illuminates how this unprecedented political upheaval produced new fissures and battle lines, as well as new opportunities for political advancement for ambitious young men such as Donald Rumsfeld, who had been Nixon’s ambassador to NATO, and Dick Cheney, already coolly efficient as Rumsfeld’s former deputy. A superbly crafted presidential history with all of the twists and turns of a thriller, 31 Days sheds new light on the key players and political dilemmas that reverberate in today’s headlines.
Author : Robert Bazell
Publisher : Random House
Page : 241 pages
File Size : 32,79 MB
Release : 2011-04-27
Category : Health & Fitness
ISBN : 0307764982
Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.
Author : Eugene H. Cordes
Publisher : Oxford University Press, USA
Page : 333 pages
File Size : 31,17 MB
Release : 2020
Category : Medical
ISBN : 0190080450
"This work provides eleven stories of drug discovery and features the scientists who made them. The outcome of the discovery work has provided novel therapies in cancer, cardiovascular medicine, antibacterial and antiviral infectious diseases, parasitic diseases, metabolic diseases, and weight control. Each story begins with the basic biomedical science that revealed the pathway to effective drug therapy and continues with the step-by-step process that leads from insight to a product in clinical practice meeting a defined medical need. The tales feature creative problem solving by clever and dedicated scientists as they overcame roadblocks to success., hallelujah moments. Each drug discovery story reflects the interface between basic science, medicine, and drug discovery. Embedded in these tales are the societal and medical environments in which drug discovery takes place, the discovery of agents to treat HIV/AIDS, for example. Finally, a series of appendices provides basic chemical background for non-scientists"--
Author : Donald L. Drakeman
Publisher : Oxford University Press
Page : 241 pages
File Size : 46,88 MB
Release : 2022
Category : Biotechnology industries
ISBN : 0195084004
"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--
Author : Barry Werth
Publisher : Anchor
Page : 353 pages
File Size : 29,73 MB
Release : 2002-03-05
Category : Biography & Autobiography
ISBN : 0385494696
During his thirty-seven years at Smith College, Newton Arvin published groundbreaking studies of Hawthorne, Whitman, Melville, and Longfellow that stand today as models of scholarship and psychological acuity. He cultivated friendships with the likes of Edmund Wilson and Lillian Hellman and became mentor to Truman Capote. A social radical and closeted homosexual, the circumspect Arvin nevertheless survived McCarthyism. But in September 1960 his apartment was raided, and his cache of beefcake erotica was confiscated, plunging him into confusion and despair and provoking his panicked betrayal of several friends. An utterly absorbing chronicle, The Scarlet Professor deftly captures the essence of a conflicted man and offers a provocative and unsettling look at American moral fanaticism.
